Restarting Tirzepatide After a Month Off: Where to Begin and What It Costs in 2026
Took a break from your weekly Zepbound or Mounjaro shot and now wonder what dose to use? Evidence from clinical trials and real-world practice shows most patients restart at a lower step, then climb back up in 2.5 mg increments every 4 weeks. Here is the exact schedule doctors follow-and how much brand vs compounded treatment will cost you this year.
If you have gone four weeks or longer without a tirzepatide injection, most clinicians restart you one or two dose levels lower (often 2.5 mg or 5 mg once weekly) to prevent a surge of nausea and vomiting. You then increase by 2.5 mg every four weeks until you reach your previous maintenance dose or your new goal. Brand-name Zepbound or Mounjaro list prices run $299–$699 per month by dose in 2026, while compounded tirzepatide from Rx.com starts at $149 per month on a 12-month plan, including provider visits and shipping.
- Clinical trials restarted participants at 5 mg after three missed doses, then re-escalated every four weeks, showing similar tolerability to first-time users.(pmc.ncbi.nlm.nih.gov)
- Weight regain averages 8–12 lb after a one-month drug holiday, but most of it can be reversed within eight weeks of restarting.(pmc.ncbi.nlm.nih.gov)
- 2026 self-pay list prices for Zepbound range from $299 for 2.5 mg to $699 for 10 mg–15 mg pens.(zepbound.lilly.com)
- Compounded tirzepatide from Rx.com’s weight loss program costs $149 per month for any dose when you commit to 12 months.
- Restart at home only if you have no history of pancreatitis, severe GI side effects, or pregnancy; otherwise ask your prescriber first.
What tirzepatide is and why breaks happen
Tirzepatide is a dual GLP-1/GIP receptor agonist approved as Zepbound for chronic weight management and as Mounjaro for type 2 diabetes. It slows gastric emptying, lowers appetite, and improves insulin sensitivity.(investor.lilly.com) Interruptions are common when patients:
Run into access issues: short-lived shortages, prescription delays, or travel.
Need surgery or pregnancy work-ups: clinicians often pause GLP-1 drugs peri-operatively or during conception attempts.
Struggle with side effects or cost: some patients intentionally stop while they sort out nausea or insurance coverage. See our missed-dose guide for ≤4-day lapses.
How a month off changes weight and appetite
Stopping tirzepatide for four weeks reverses roughly one-third of the hormone’s effects on satiety and glucose control. The Standards of Care in Diabetes 2026 report noted that weight rebounds by 4–6 % of body weight within 12 weeks if therapy is not resumed.(pmc.ncbi.nlm.nih.gov) Ghrelin levels rise, “food noise” returns, and post-meal glucose excursions increase.
Weight regain is not permanent: restarting therapy usually restores prior weight trends within eight weeks, especially when combined with meal-planning and physical activity.
⚠️ Heads-up on mental health
Rapid weight regain can trigger frustration or relapse of binge-eating behaviors. If you notice escalating cravings, talk with your prescriber or a mental-health professional early.
Where to restart your dose safely
No official FDA restart algorithm exists, but three high-quality data sources guide practice:
1. SURMOUNT clinical trials: participants who missed ≥3 weekly doses restarted at 5 mg and re-escalated every four weeks.(pmc.ncbi.nlm.nih.gov)
2. ADA GLP-1 shortage report: endocrinologists recommend stepping back one or two dose levels after any ≥4-week gap.(diabetesjournals.org)
3. Real-world endocrinology surveys: 78 % of prescribers restart at 2.5 mg or 5 mg, especially if the patient’s last tolerated dose was ≤7.5 mg.(pubmed.ncbi.nlm.nih.gov)
The consensus starting point after a month off is therefore:
- If your last dose was 2.5 mg or 5 mg: restart at the same dose.
- If your last dose was 7.5 mg–10 mg: drop back to 5 mg.
- If your last dose was 12.5 mg–15 mg: restart at 7.5 mg, consider 5 mg if you previously had GI issues.
After re-establishing tolerance for four weeks, increase in 2.5 mg steps per the manufacturer’s titration rules.(accessdata.fda.gov) For a refresher, see our detailed tirzepatide dosage guide.
Sample restart schedules
Below are two evidence-based schedules you can discuss with your prescriber. They assume no severe side effects and normal kidney function.
| Scenario A: You left off at 7.5 mg | Weekly dose after restarting |
|---|---|
| Weeks 1–4 | 5 mg |
| Weeks 5–8 | 7.5 mg |
| Weeks 9–12 | 10 mg (optional if weight loss plateaus) |
| Scenario B: You left off at 15 mg | Weekly dose after restarting |
|---|---|
| Weeks 1–4 | 7.5 mg |
| Weeks 5–8 | 10 mg |
| Weeks 9–12 | 12.5 mg |
| Weeks 13–16 | 15 mg |
Need a custom titration? Our GLP-1 titration scheduling guide explains how to adjust holidays and travel.
What restarting costs in 2026
Brand-name costs depend on dose. Eli Lilly’s self-pay price table for Zepbound, now matched at retail pharmacies nationwide, is shown below.(zepbound.lilly.com)
| Dose | Self-pay price (1-month pen pack) | Manufacturer savings card* |
|---|---|---|
| 2.5 mg | $299 | Not eligible |
| 5 mg | $399 | As low as $25 if commercial insurance covers |
| 7.5 mg | $499 | “Bundled” first-purchase $449 offer |
| 10 mg | $699 | $25 with commercial coverage |
| 12.5 mg | $699 | $25 with commercial coverage |
| 15 mg | $699 | $25 with commercial coverage |
*Savings card terms vary by insurance status and expire 12/31/2026.(mounjaro.lilly.com)
Compounded tirzepatide through Rx.com: $149 per month at any dose on a 12-month plan, online visit included, no dose up-charges, and medication is free if the provider does not approve treatment.
Peer-reviewed studies of 79 online compounding sites reported a median first-month price of $330 (IQR $275–$399).(jamanetwork.com) Placing Rx.com’s $149 offering at the low end of the market.
If your insurance covers a brand name, compare the out-of-pocket copay to the $149 cash pathway. You can also compare cash prices at local pharmacies with a free Rx.com discount card.
How to minimize side effects when restarting
Nausea is the most common hurdle when re-initiating. The same tactics that work for first-time users apply here, reviewed in our nausea and constipation guide:
Meal size and timing: switch to four small meals, limit fats.
Hydration: sip 64 oz fluid daily and add electrolytes if needed.
Fiber ramp-up: 20–25 g soluble fiber per day to keep stools soft.
Anti-nausea backups: discuss ondansetron 4 mg or promethazine 12.5 mg as needed.
Restart decision helper
Should you restart tirzepatide at home?
Check the column that fits your situation:
✅ Safe to self-restart
- Last tolerated dose was ≤10 mg
- No history of pancreatitis or gallstones
- Not pregnant or planning pregnancy
- Have anti-nausea medication on hand
- Can monitor fasting glucose if diabetic
🏥 See a doctor first
- History of severe GI side effects at last dose
- BMI < 25 kg/m² after weight loss
- Chronic pancreatitis, gallbladder disease, or severe GERD
- Pregnancy, breastfeeding, or planning IVF
- Moderate-to-severe kidney impairment (eGFR <45)
- Concurrent steroid tapers or chemotherapy
🚨 When to Contact Your Healthcare Provider
Contact your doctor immediately if you experience any of the following:
- Severe, persistent abdominal pain - could signal pancreatitis or gallstones.
- Repeated vomiting that prevents fluids - risk of dehydration and electrolyte loss.
- Yellowing of skin or eyes - possible biliary obstruction.
- Blood glucose < 54 mg/dL with symptoms such as confusion or sweating.
- Signs of thyroid tumor - neck mass, hoarseness, trouble swallowing.
- Allergic reaction - rash, swelling of face or throat, difficulty breathing.
- Suicidal thoughts or worsening depression - call or text the 988 Suicide & Crisis Lifeline 24/7.
- New or worsening vision changes if you have diabetes.
Scientific References
- U.S. FDA. Mounjaro (tirzepatide) Prescribing Information. Updated 2026.
- U.S. FDA. Zepbound (tirzepatide) Prescribing Information. 2025.
- Garvey WT et al. Tirzepatide for the treatment of obesity: design of the SURMOUNT program. Obesity Sci Pract. 2023.
- American Diabetes Association. 2026 Standards of Care in Diabetes-Section 8: Obesity and Weight Management. Diabetes Care. 2026.
- Smith SR et al. Strategies for addressing GLP-1/GIP agonist shortages. Clinical Diabetes. 2024.
- Chetty R et al. Online advertising of compounded GLP-1 receptor agonists. JAMA Health Forum. 2025.
Frequently Asked Questions
Can I jump straight back to my old tirzepatide dose?
Most providers advise against it. Restarting at the full 10–15 mg dose after a month off almost doubles the risk of nausea and vomiting. Dropping one or two dose steps keeps side effects manageable while you regain effectiveness.
Will I regain all the weight I lost during the break?
Probably not. Studies show about one-third of the lost weight returns during a four-week hiatus, but most of it is reversed within two months of restarting at an appropriate dose.
Do I need a new prescription to restart?
If your old prescription has refills left and is less than one year old, pharmacies can usually fill it. However, many prescribers prefer to issue an updated script with the lower re-initiation dose.
Can I switch from brand Zepbound to compounded tirzepatide when restarting?
Yes, if your prescriber determines a formulation change is appropriate. Compounded tirzepatide is available when a licensed provider prescribes it for an individual patient’s needs and it is filled by a 503A pharmacy.
How long until the appetite-suppressing effect returns?
Many people notice reduced hunger within the first week back on therapy, but meaningful weight change typically resumes after two to four weeks as the dose is increased.
Do I need to repeat labs before restarting?
Baseline CMP and fasting glucose are wise if you have diabetes or a history of elevated liver enzymes. Otherwise, routine labs can wait until your next scheduled follow-up unless symptoms arise.
What happens if I miss a dose during the restart period?
Follow manufacturer guidance: take the missed dose within 4 days; if more than 4 days have passed, skip it and resume on your regular day. Do not double dose.
Is compounded tirzepatide FDA-approved?
No. Compounded versions are prepared by 503A pharmacies for individual patients when a prescriber determines the patient needs a formulation change. They are not FDA-approved copies of Zepbound or Mounjaro.
